IGF-1 LR3 PEPTIDE 1MG/10MG VIAL

Price range: $59.99 through $499.99

High-purity IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) (≥99.0% (HPLC Analyzed)). Formulated for analytical research applications.

≥99% HPLC Purity Certified
100% USA Synthesized
Same-Day US Dispatch
ISO-Accredited Lab Tested
SKU: N/A Categories: ,

Description

IGF-1 LR3 PEPTIDE 1MG/10MG VIAL

IGF-1 LR3 is a synthetic analog of human insulin-like growth factor-1 modified with an Arg substitution at position 3 and a 13-amino acid N-terminal extension, significantly reducing affinity for IGF-binding proteins.

Chemical Specifications & Product Details:

  • Product Title: IGF-1 LR3 PEPTIDE 1MG/10MG VIAL
  • Active Compound: IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1)
  • Classification: Modified Recombinant Polypeptide
  • CAS Number: 946870-92-4
  • Chemical Formula: C400H625N111O115S9
  • Molecular Mass: 9117.50 g/mol
  • Purity Specification: ≥99.0% (HPLC Analyzed)
  • Recommended Storage: Store lyophilized vial at -20°C or 2°C – 8°C.

Quality Assurance & Analytical Standards:

Every batch of research compounds and peptides from Umbrella Labs undergoes third-party HPLC and LC-MS testing to guarantee maximum purity, concentration, and authentic chemical identity.

Disclaimer: This product is synthesized and supplied strictly for in-vitro laboratory research and analytical testing. Not for human or veterinary administration.

Batch Certificate of Analysis & HPLC Validation

Every production lot manufactured by Umbrella Lab Solution is submitted to independent, ISO-accredited American analytical laboratories for quantitative purity quantification via High-Performance Liquid Chromatography (HPLC) and structural identity confirmation via Mass Spectrometry (LC-MS).

Certificate of Analysis Preview

Browse Full Research Catalog →

Additional information

Dosage

5mg Vial, 10mg Vial, 10x Multi-Pack

Reviews

There are no reviews yet.

Be the first to review “IGF-1 LR3 PEPTIDE 1MG/10MG VIAL”

Your email address will not be published. Required fields are marked *